Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 19, 2013
Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that Adrian Raiche, Ph.D. has joined the company as Director of Formulation Development.
read more
Emergent BioSolutions has announced that its Center for Innovation in Advanced Developmentand Manufacturing (CIADM) has received a task order from the Biomedical Advanced Research and Development Authority (BARDA) valued at up to $21.9 million to ...
read more
Thursday, October 07, 2021
Brooks Automation announces Brooks Life Sciences Services and Products businesses will be rebranded under the creation of a new identity – Azenta Life Sciences (“Azenta”). Azenta will bring together our existing portfolio of life sciences products ...
read more
Thursday, January 23, 2020
Palladium Equity Partners has acquired Accupac from J.H. Whitney Capital Partners.
read more
Wednesday, November 11, 2020
Centogene and Fujirebio Europe have entered a partnership to leverage LUMIPULSE G technology for large-scale COVID-19 antigen testing with further deployment in German airports.
read more
Ablynx has entered into a research collaboration and global exclusive licensing agreement with Sanofi initially focused on developing and commercializing Nanobody-based therapeutics.
read more
Wednesday, February 28, 2018
Median Technologies and CMIC announced a collaborative agreement for comprehensive clinical trial services.
read more
QIAGEN announced a partnership with multiple organizations to support creating a global genomics campus in Manchester, U.K.
read more
Wednesday, August 29, 2018
The FDA issued a Federal Register notice proposing not to include three bulk drug substances on the list of bulk drug substances that outsourcing facilities may use in compounding under section 503B of the 503B bulks list.
read more
Tuesday, November 21, 2017
Fresenius Kabi will expand its manufacturing operations in Wilson County, Governor Roy Cooper announced.
read more
Thursday, December 19, 2024
Catalent, Inc. and Novo Holdings A/S announced that Novo Holdings has completed its previously announced acquisition of Catalent in an all-cash transaction with a total enterprise value of approximately $16.5 billion.
read more
Scenic Biotech announced a license and research agreement with Alnylam Pharma to leverage Scenic's Cell-Seq platform for discovering novel targets for RNAi therapeutics.
read more
Allele Biotechnology & Pharmaceuticals has received a Tissue Bank License from the California Department of Public Health.
read more
Abzena announced an accelerated program to IND.
read more
ProBioGen and LAVA Therapeutics N.V. announced the closing of a second cell line development agreement to support a bispecific gamma-delta T cell engager (TCE) candidate in LAVA's pipeline.
read more